Uncategorized

Regeneron did not bid higher on the genetic testing company because of “its assessment of 23andMe’s remaining value,” according to a spokesperson for the pharma.

Analysts at Jefferies give Roche and Prothena’s Phase III study just a 25% to 40% probability of success.

The data released by a group of Democrat lawmakers found 338 rural hospitals were at risk of closure, conversion or service cutbacks if the reconciliation bill becomes law.

At 12 weeks, weight loss ranged from 2.6% to 11.3%, compared to a gain of 0.2% in the placebo group. Guggenheim analysts were also impressed by the tolerability profile.

Analysts at Truist Securities called J&J’s CAR-T readout “compelling,” noting that the efficacy figures could position the cell therapy as a formidable competitor to the current standard of care, Gilead’s Yescarta.

Aunque el vals del Danubio Azul, compuesto por Johann Strauss hijo en 1866, está dedicado al río Danubio, la inclusión de esta pieza musical en la banda sonora de la legendaria película de ciencia-ficción “2001, una odisea del espacio” (1968), donde aco …

Stifel analysts said the deal “feels like an unremarkable outcome for a company that was once one of the hottest stories in CNS.” Supurnus’ offer beats Biogen’s unsolicited bid of about $7.22 per share, which arrived with a thud in late January.

Sarepta’s shares crashed 41% in pre-market trading Monday morning to $21.01 after the biotech reported a second death from acute liver failure, a known side effect of adeno-associated virus-based gene therapies.

According to an internal email, the agency may be in for more consolidation in areas including human resources, communications, travel and acquisitions.

Hace más de una década que se cultivan organoides (pequeños grupos de células que reproducen la estructura básica de un órgano específico) para que sirvan como modelos biológicos en miniatura de tales órganos. Los organoides cerebrales s …